## 5 Future Challenges and Conclusions
Extracell Vesicles_**2018**, \(7\), 1470442. [CrossRef]
* (190) [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON]; [PERSON] [PERSON]; [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; et al. Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer. _Br. J. Cancer_**2015**, _113_, 275-281. [CrossRef]
* (191) [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; et al. Circulating exosomal microRNAs as biomarkers of colon cancer. _PLoS ONE_**2014**, \(9\), e92921. [CrossRef] [PubMed]
* (192) [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON] [PERSON]; [PERSON]; [PERSON]; et al. Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity. _Int. J. Cancer_**2015**, _136_, 2616-2627. [CrossRef] [PubMed]
* (193) [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; et al. Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer. _Eur. Ulrol._**2015**, _67_, 33-41. [CrossRef] [PubMed]
* (194) [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON] Exosomal microRNA-141 is upregulated in the serum of prostate cancer patients. _Onc Targets_**2015**, \(9\), 139-148. * (195) [PERSON]; [PERSON]; [PERSON] Protocol for serum exosomal miRNAs analysis in prostate cancer patients treated with radiotherapy. _J. Transl. Med._**2018**, _16_, 223. [CrossRef]
* (196) [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON] [PERSON]; [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; et al. Plasma Small Extracellular Vesicles Derived miR-21-5p and miR-92a-3p as Potential Biomarkers for Hepatocellular Carcinoma Screening. _Front. Genet._**2020**, _11_, 712. [CrossRef]
* (197) [PERSON]; [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON]; [PERSON]; et al. Circulating extracellular vesicles from individuals at high-risk of lung cancer induce pro-tumorigenic conversion of stromal cells through transfer of miR-126 and miR-320. _J. Exp. Clin. Cancer Res._**2021**, _40_, 237. [CrossRef]
* (198) [PERSON]; [PERSON] Serum Exosomes and Their miRNA Load-A Potential Biomarker of Lung Cancer. _Cancers_**2021**, _13_, 1373. [CrossRef]
* (199) [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON] [PERSON]; [PERSON]; [PERSON]; et al. Identification of miRNAs Enriched in Extracellular Vesicles Derived from Serum Samples of Breast Cancer Patients. _Biomolecules_**2020**, _10_, 150. [CrossRef]
* (200) [PERSON]; [PERSON]; [PERSON]; [PERSON] [PERSON]; [PERSON]; [PERSON]; [PERSON] [PERSON] miR-200-containing extracellular vesicles promote breast cancer cell metastasis. _J. Clin. Invest._**2014**, _124_, 5109-5128. [CrossRef]* [PERSON] et al. (2017) [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON]; [PERSON]; [PERSON] [PERSON]; [PERSON]; [PERSON] Breast cancer-secreted miR-939 downregulates VE-cadherin and destroys the barrier function of endothelial monolayers. _Cancer Lett._**2017**, _384_, 94-100. [CrossRef] [PubMed]
* [PERSON] et al. (2017) [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON]; [PERSON]; [PERSON] [PERSON]; [PERSON] [PERSON] Differential expression of exosomal miRNAs between breast cancer patients with and without recurrence. _Oncotarget_**2017**, \(8\), 69934-69944. [CrossRef]
* [PERSON] et al. (2018) [PERSON]; [PERSON] [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON] Exosomes derived from hypoxic epithelial ovarian cancer cells deliver microRNAs to macrophages and elicit a tumor-promoted phenotype. _Cancer Lett._**2018**, _435_, 80-91. [CrossRef]
* [PERSON] et al.